Literature DB >> 19513669

Methods for assessing binding of mitochondrial transcription factor A (TFAM) to DNA.

Atsushi Fukuoh1, Dongchon Kang.   

Abstract

It is now recognized that mammalian mitochondrial DNA forms a higher structure called the nucleoid, corresponding to the nucleosome of nuclear DNA. Mitochondrial transcription factor A (TFAM), which was cloned as a transcription factor for mitochondrial DNA, is essential for the maintenance of mitochondrial DNA. In fact, TFAM markedly enhances the promoter-specific transcription of mitochondrial DNA. In addition, TFAM has an ability to bind to DNA in a sequence-independent manner and is abundant enough to cover an entire region of mitochondrial DNA. Over-expression of human TFAM in cells increases the amount of mitochondrial DNA almost in parallel with the TFAM. TFAM may stabilize mitochondrial DNA by packaging and regulate (or titrate) the amount of mitochondrial DNA. Thus, TFAM may play a crucial role in maintaining mitochondrial DNA as a main component of the nucleoid (or more appropriately mitochromosome).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513669     DOI: 10.1007/978-1-59745-521-3_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer.

Authors:  Jianhui Guo; Li Zheng; Wenyong Liu; Xianshu Wang; Zemin Wang; Zehua Wang; Amy J French; Dongchon Kang; Lin Chen; Stephen N Thibodeau; Wanguo Liu
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

2.  Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism.

Authors:  Rina Fujiwara-Tani; Takamitsu Sasaki; Tadataka Takagi; Shiori Mori; Shingo Kishi; Yukiko Nishiguchi; Hitoshi Ohmori; Kiyomu Fujii; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.